Short description
Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders.
Description
Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EU and the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Total funding
$$2020202
Sign in for full access
Location
Mölndal, Vastra Gotaland, Sweden, Europe
Founded on
January 1, 2009
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Cannot Access, Absolutely Noaccess, Uh Ohhhh, Noway Youcantaccess, No Way, Blurry Noaccess, Uh Ohhhh, Noway Youcantaccess, Absolutely Noaccess
Sign in for full access